FIELD: radiobiology; medicine.
SUBSTANCE: invention relates to radiobiology and medicine, namely to use of lithium pyruvate with general formula LiC3H3O3 as a radioprotective agent. Use of lithium pyruvate increases the viability of the population of irradiated cells, and can be used for protecting healthy tissues from radiation damage, for example, in radiation therapy.
EFFECT: invention extends range of products possessing radioprotective activity.
1 cl, 1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| RADIOSENSITIZER | 2019 |
|
RU2720455C1 |
| RADIOPROTECTIVE, RADIOMITIGATORY AND RADIOSENSITIZING AGENT BASED ON SODIUM SALT OF AMINODIHYDROPHTHALAZINEDIONE SODIUM (DRUG TAMERON) AND OTHER ALKALI AND ALKALINE EARTH METAL SALTS OF AMINODIHYDROPHTHALAZINEDIONE | 2022 |
|
RU2804886C1 |
| METHOD FOR OBTAINING THE TRILITHIUM SALT OF PHOSPHO-ASCORBIC ACID | 2020 |
|
RU2752829C1 |
| METHOD OF PROTECTING ANIMALS FROM HIGH-DOSE IONIZING RADIATION | 2019 |
|
RU2701155C1 |
| MEANS WITH RADIO SENSITIZING EFFECT | 2021 |
|
RU2763884C1 |
| METHOD OF APPLYING VEGETABLE POLYSACCHARIDE AS RADIOPROTECTOR AND STIMULATOR OF COLONY FORMATION OF SPLEEN STEM CELLS IN IRRADIATED ANIMALS | 2013 |
|
RU2537033C1 |
| AGENT FOR RADIATION DISEASE PREVENTION | 1998 |
|
RU2161973C2 |
| SUBSTANCE SHOWING RADIOPROTECTIVE EFFECT | 1993 |
|
RU2104007C1 |
| CARDIOPROTECTIVE AGENT | 2020 |
|
RU2743764C1 |
| AGENT POSSESSING SELECTIVE RADIO- AND CHEMOPROTECTIVE ACTION | 2007 |
|
RU2339386C1 |
